CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Follow-Up Questions
What is the price performance of CLGN stock?
The current price of CLGN is $2.64, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Collplant Biotechnologies Ltd?
Collplant Biotechnologies Ltd belongs to Biotechnology industry and the sector is Health Care
What is Collplant Biotechnologies Ltd market cap?
Collplant Biotechnologies Ltd's current market cap is $33.5M
Is Collplant Biotechnologies Ltd a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for Collplant Biotechnologies Ltd, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell
